gammalyte9000 at yahoo.com
Sun Dec 14 15:36:16 EST 2003
one of the scarier tactics is the US Pharmaceutical Industry's practice of
exportation of un-tested, un-approved or expired medications to 3rd world
countires where they are sold for TOP dollar (and are known to be innefective
or worse, detrimental)
Lets remember exactly who these pharms really are, born from the petro-chemical
companies who demonized healing herbs like marijuana (whose healing and
agricultural values were replaced by patent-able "medicine and other
chemicals"). Who do you think was a major funder behind the marijuana scare?
Yep. Companies like DOW, and the list goes on.
I have this love-hate relationship with pharms. I love their narcotics but hate
just about everything else about them. :^) including their price gouging.
--- Sara Glatt <sara119 at xs4all.nl> wrote:
> A senior executive at Europe's largest drug maker has admitted most
> prescription medicines don't work for most people, it is reported.
> Allen Roses, of GlaxoSmithKline, is quoted in a national newspaper as
> saying more than 90% of drugs only work in 30-50% of people.
> He said: "Drugs on the market work, but they don't work in everybody."
> Mr Roses, an expert in genetics, said new developments should help
> tailor drugs more specifically.
> At present, pharmaceutical companies adopt a "one-drug-fits-all" policy.
> But Mr Roses said refinements in genetic technology should make it
> possible to identify more precisely those people who were likely to
> benefit from a drug.
> He said: "By eliminating the people that we predict will be
> non-responders we'll be able to do smaller, faster and cheaper drug
> "If you can determine who is going to have a response (to a drug) and
> who is not going to have a response, you can take your next molecule and
> aim it specifically at the people who haven't had a response with the
> first one so that you can create a set of drugs that cover the
> population, and then you are back to selling to everybody."
> Big differences
> GSK announced last week that it had more than 20 potential $1
> billion-a-year blockbuster drugs in development.
> Mr Roses quoted research published three years ago by Brian Spear, an
> expert in medical diagnostics, which found that different drugs had
> vastly different success rates in treating patients.
> Most drugs had an efficacy rate of 50% or lower.
> Richard Ley, a spokesman for the Association of the British
> Pharmaceutical Industry, told BBC News Online, said Mr Roses' comments
> emphasised just how important it was to conduct research into new
> He said: "It's not news to anyone that not all drugs work in all people
> all the time.
> "Sometimes the government and the National Institute for Clinical
> Excellence want to try to find one drug for a particular condition.
> "This shows quite clearly that is not a viable approach. A medicine
> might work well in one person, and not at all for another."
> Hey, that is true!
> Also, it is the same with natural herbs and Iboga, it doesn't "waken
> up" everyone.
> There is not one dosage that fits to everyone needs, there is "not one
> way "which is the best way for everyone
> Some like sweet and some salt, I write this because it looks like that
> EU are going to have new regulation.
> Who Is going to stand up and say: we want more freedom AND NOT MORE
> REGULATIONS, after all
> The pharma. Are not that good for everyone, and there was a place for
> progress, why stop it?
Do you Yahoo!?
New Yahoo! Photos - easier uploading and sharing.
More information about the Ibogaine